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Hedgehog (Hh) signaling is required for osteoblast
differentiation from mesenchymal progenitors during
endochondral bone formation. However, the role of
Hh signaling in differentiated osteoblasts during adult
bone homeostasis remains to be elucidated.We found
that in the postnatal bone, Hh signaling activity was
progressively reduced as osteoblastsmature. Upregu-
latingHhsignaling selectively inmatureosteoblasts led
to increased bone formation and excessive bone
resorption. As a consequence, these mutant mice
showed severe osteopenia. Conversely, inhibition of
Hh signaling in mature osteoblasts resulted in in-
creased bone mass and protection from bone loss in
older mice. Cellular and molecular studies showed
thatHhsignaling indirectly inducedosteoclastdifferen-
tiationbyupregulatingosteoblastexpressionofPTHrP,
which promoted RANKL expression via PKA and its
target transcription factor CREB. Our results demon-
strate thatHhsignaling inmature osteoblasts regulates
both bone formation and resorption and that inhibition
of Hh signaling reduces bone loss in aged mice.
INTRODUCTION
Bone tissue in adult mammalian animals undergoes continuous
remodeling through a tightly controlled balance between bone
formation and resorption. This balance is required to maintain
physiological bone mass, a critical indicator of bone quality.
Osteoblasts, which differentiate from mesenchymal progenitor
cells in the bone marrow or periosteum, are responsible for
bone formation (reviewed by Harada and Rodan, 2003; Karsenty
andWagner, 2002), whereas osteoclasts, which are derived from
mononucleated hematopoietic cell lineage (Ash et al., 1980), are
responsible for bone resorption. Osteoblasts also regulate bone
resorption via inducing osteoclast differentiation by secreting the
receptor activator of NFkB ligand (RANKL), monocyte colony
stimulating factor (M-CSF), and osteoprotegerin (OPG) (Lacey
et al., 1998; Lagasse and Weissman, 1997). RANKL is essential674 Developmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc.for osteoclast differentiation. RANKL administration leads to
bone resorption (Lacey et al., 1998), and RANKL-deficient mice
are osteopetrotic due to the lack of osteoclast differentiation
(Kim et al., 2000; Kong et al., 1999). OPG is a soluble tumor
necrosis factor (TNF) a receptor that inhibits osteoclast differen-
tiation by acting as a decoy receptor for RANKL (Lacey et al.,
1998; Simonet et al., 1997; Yasuda et al., 1998). Abnormal ratios
of RANKL and OPG caused by diseases, cancer metastases,
and aging lead to either osteoporosis or osteopetrosis (Blair
et al., 2006; Hofbauer and Schoppet, 2004; Whyte, 2006). There-
fore, the balance of RANKL and OPG produced in osteoblasts
needs to be tightly controlled to maintain bone mass.
Activated canonical Wnt signaling in osteoblasts increases
bone mass by inhibiting osteoclast differentiation through upre-
gulatingOPG expression (Glass et al., 2005; Holmen et al., 2005).
It is conceivable that other signaling pathways may control bone
mass by regulating RANKL expression. A widely studied bone
anabolic factor, parathyroid hormone (PTH), acts systemically
to regulate bone mass. Parathyroid hormone-related protein
(PTHrP) that resembles PTH in its aminoterminal sequence
(Karmali et al., 1992; Strewler et al., 1987; Suva et al., 1987; Tsu-
kazaki et al., 1995) and biological activities (Juppner et al., 1991;
Kemp et al., 1987; Nissenson et al., 1988) is produced locally in
articular chondrocytes and osteoblasts. PTH/PTHrP promotes
differentiation and survival of osteoblasts (Miao et al., 2005),
which in turn upregulate RANKL expression to induce osteoclast
differentiation (Thomas et al., 1999). Consistent with this notion,
PTH induces osteoclast formation from PTHR1-deficient pre-
cursors when they are cocultured with PTHR1-expressing bone
marrow stromal cells. Therefore, PTH/PTHrP signaling can act
in osteoblasts to indirectly induce osteoclast formation through
another signaling pathway (Liu et al., 1998).
Hedgehog (Hh) signaling is required for endochondral bone
formation during embryonic development. Mice lacking Indian
hedgehog (Ihh) fail to form osteoblasts or activate PTHrP expres-
sion in articular chondrocytes (St-Jacques et al., 1999). Ihh is
also expressed in growth plate chondrocytes and osteoblasts
postnatally in mice and rats (Jemtland et al., 2003; Murakami
et al., 1997; Murakami and Noda, 2000; van der Eerden et al.,
2000). IHH expression is also found in postnatal human growth
plates (Kindblom et al., 2002). Reduced Ihh expression in
postnatal chondrocytes leads to reduced trabecular bone
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Hh Controls Bone Homeostasis via PTHrP and RANKLFigure 1. Hh Signaling Is Progressively Re-
duced as Osteoblasts Mature
(A) Hh signaling activity was shown by LacZ ex-
pression in the distal humerus from a P5 Ptch1+/
mouse detected by X-gal staining. Early (yellow
box) and late periosteum (black box) are shown
in higher magnification in (C) and (E), respectively.
(B) HOC-Cre activity was shown by LacZ expres-
sion in the distal humerus from a P3 R26R;HOC-
Cre mouse (Soriano, 1999) detected by X-gal
staining. Early (yellow box) periosteumand trabec-
ular bone (black box) are shown in higher magnifi-
cation in (D) and (F), respectively.
(C) Early differentiated osteoblasts (arrow) showed
strong Hh signaling activity.
(D) HOC-Cre activity was not detected in early
differentiated osteoblasts (arrow).
(E) Mature osteoblasts and osteocytes (arrow)
showed greatly reduced Hh signaling activity.
(F) HOC-Cre activity was detected in mature oste-
oblasts and osteocytes (arrow).
NH, nonhypertrophic chondrocytes; H, hypertro-
phic chondrocytes; TB, trabecular bone.(Maeda et al., 2007). However, it is unclear if the observed
defects are caused by reduced osteoblast differentiation from
mesenchymal progenitors. It remains to be elucidated whether
Hh signaling in differentiated osteoblasts controls postnatal
bone formation and remodeling.
Vertebrate Hh signaling is transduced through two multipass
transmembrane proteins, Smoothened (Smo) and Patched1
(Ptch1) (reviewed by Huangfu and Anderson, 2006). In the ab-
sence of Hh ligands, Smo signaling activity is inhibited by
Ptch1. Such inhibition is relieved when Hh ligands bind Ptch1, al-
lowing Smo to transduce Hh signal to intracellular components.
As a major pathway regulating cell proliferation, differentiation,
and survival during embryonic morphogenesis, Hh signaling
strength is tightly controlled. Ptch1, a negative regulator and
a transcriptional target of Hh signaling, acts as a critical ‘‘guard-
ian’’ of Hh signaling activities in both embryonic development
and adult tissue homeostasis. Ptch1 is a well-established onco-
suppressor (Goodrich et al., 1997; Johnson et al., 1996; Oro
et al., 1997). Reduced Ptch1 activity causes theGorlin Syndrome
in humans, which shows skeletal abnormalities and predisposi-
tion to several types of tumors (reviewed by Rubin and de
Sauvage, 2006).
Here, we have addressed the function of Hh signaling in oste-
oblasts during postnatal bone homeostasis by generating mice
in which Hh signaling is either activated or blocked genetically
in mature osteoblasts. Activation of Hh signaling increased
bone formation, but the resulting bone is very fragile and porous
due to severe bone resorption. Furthermore, we found that, as in
the developing cartilage (St-Jacques et al., 1999; Vortkamp
et al., 1996), upregulated Hh signaling inmature osteoblasts pro-
motes PTHrP expression. PTHrP signals via PKA and CREB to
upregulate RANKL expression. Conversely, loss of Hh signaling
resulted in increased bone mass and much reduced bone loss in
older mice. Our results have uncovered a novel role of Hh signal-
ing, which is to promote bone resorption and identified upregu-Dlation of Hh signaling in mature osteoblasts as a key event in
causing osteoporosis.
RESULTS
Hh Signaling Progressively Decreases
as Osteoblasts Mature
To determine Hh signaling activity in postnatal bone, we tested if
Ptch1, a transcriptional target of Hh signaling, was expressed in
the postnatal skeletal system using a LacZ knockin null allele of
Ptch1, which was derived from a floxed allele of Ptch1 (Mak
et al., 2006). After Cre-mediated recombination, the LacZ gene
is brought under the control of the Ptch1 regulatory elements.
We assessed Hh signaling activity by X-gal staining of these
Ptch1+/ mice at postnatal day 5 (P5) and focused our analysis
on the perichondrium and bone in the forelimbs. Strong staining
was found in the perichondrium in the Ptch1+/ mice (Figures
1A and 1C) and progressively reduced as the osteoblasts be-
came more mature in the cortical and trabecular bone (Figures
1C and 1E). There was no detectable staining in the osteocytes
(Figure 1E). In addition, X-gal staining was detected in the calva-
rial osteoblasts of both P5 and one-year-old mice (see Figure S1
in the Supplemental Data available with this article online). Again,
as osteoblasts matured and grew further away from the suture,
X-gal staining was reduced progressively (Figures S1A and S1B).
These results suggest that Hh signaling may need to be properly
downregulated in mature osteoblasts of the postnatal bone.
Activation of Hh Signaling in Mature Osteoblasts
Leads to Severe Osteopenia
Progressively weakened Hh signaling inmature osteoblasts sug-
gests that sustained high levels of Hh signaling in these cells is
likely to be deleterious to the adult bone. To test this, we acti-
vated Hh signaling by crossing the mice carrying a floxed allele
of Ptch1 (Mak et al., 2006) with the human Osteocalcin-Creevelopmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc. 675
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Hh Controls Bone Homeostasis via PTHrP and RANKLFigure 2. Cell-Autonomous Upregulation of Hh Signaling in Osteoblasts Leads to Severe Osteopenia
(A) The Ptch1c/;HOC-Cremice were much smaller in size compared to the wild-type littermates at P52. The skull was dome shaped and bossing. The eyes were
further apart as indicated by white lines.
(B) mCT images of sagittal sections of the femur of P52 mice. Three-dimensional images of the bracketed trabecular bone region were shown in (C). Three mice of
indicated genotypes were analyzed.
(D) van Gieson staining of P52 mouse tibia sections. Trabecular (arrow) and cortical bone (arrowhead) are shown.
(E) H & E staining of the trabecular region of P52 mouse humerus to show osteoblasts (arrow).
(F) TRAP staining of the trabecular region of P52 mouse humerus to show osteoclasts (arrow).
(G) Histomorphometric analysis of bone parameters in the femur of P52 mice. Bone mass and bone volume were significantly reduced in the Ptch1c/;HOC-Cre
mouse. Three individual samplesof eachgenotypewere analyzed. In all figures, asterisks represent statistical significance (p<0.05) according to theStudent’s t test.(HOC-Cre) mice that express the Cre recombinase in mature
osteoblasts and osteocytes (Zhang et al., 2002 and Figures
1B, 1D, and 1F) to obtain the Ptch1c/;HOC-Cre mice. These
mice appeared normal at birth and were born at the expected
Mendelian ratio. However, a significant growth retardation was
observed (Figure S2A). The skull was bigger and dome shaped,
and the eyes were further apart from each other in the mutant
(Figure 2A). These phenotypes resemble the skull and facial fea-
tures (frontal, biparetial, or temporal bossing; large calvaria; and
hypertelorism) of Gorlin Syndrome patients, which have reduced
PTCH1 activity (Balsa et al., 1985; Lambrecht and Kreusch,
1997; Lo Muzio et al., 1999). Many of the Ptch1c/;HOC-Cre
mice had difficulties in walking and breathing, likely due to the
smaller rib cages and lower bone density (Figure S2B). The
long bones were more fragile in the Ptch1c/;HOC-Cre mice as
fractures were frequently observed in at least one limb of the676 Developmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc.mutantmouse (Figure S2B). In contrast to the reduced bone den-
sity, significant bone overgrowth in rib, humerus, and femur of
the Ptch1c/;HOC-Cre mice was revealed by computed tomog-
raphy (CT) scan (Figure S2C). In addition, the serum alkaline
phosphatase activity, a bone formation marker, was also higher
in the mutant than the wild-type (Figure S2E). These observa-
tions prompted us to examine the bone quality by microcom-
puted tomography (mCT) analysis. The cortical and trabecular
bone mass were greatly reduced in most areas of the Ptch1c/;
HOC-Cre mice, and the trabecular number was significantly re-
duced (Figures 2B, 2C, and 2G) with an increased ratio of bone
surface to volume (Figure 2G). These results indicate that in the
Ptch1c/;HOC-Cre mice, bone formation is increased, but the
formed bone is more porous due to accelerated bone turnover.
Reduced bone mass was also observed in the membranous
bone of the skull (Figure S2D). Thus, in contrast to the limited
Developmental Cell
Hh Controls Bone Homeostasis via PTHrP and RANKLrole of Ihh in endochondral bone formation in embryonic devel-
opment (St-Jacques et al., 1999), activation of Hh signaling in
the mature osteoblasts resulted in marked reduction in bone
mass regardless of the ossification mechanism.
Hh Signaling Promotes Both Bone
Formation and Resorption
To investigate bone formation and resorption of the Ptch1c/;
HOC-Cre mice in more detail, we sectioned the tibia of P52
mice and performed Van Gieson staining by which collagen in
the bone matrix is stained red and smooth muscle cells are
stained yellow (Figure 2D). In the Ptch1c/;HOC-Cre limb, the
primary and secondary spongiosa were present, indicating
that upregulation of Hh signaling in mature osteoblasts does
not affect chondrocyte hypertrophy and maturation (Fig-
ure S3). However, both the cortical and trabecular bones
were much thinner, and the primary spongiosa region was ex-
panded by massive bone marrow invasion in the mutant
(Figure 2D). In some areas of the bone, there was obviously
more bone growth, but the resulting bone was more porous
(Figure 2D). These results suggest that the normal balance of os-
Figure 3. Osteoblast Proliferation and Sur-
vival Are Increased in the Ptch1c/;HOC-
Cre Mice
(A) Fluorescent immunohistochemistry of PCNA
(green, arrow) in the trabecular region of P23
mouse humerus.
(B) Statistical analysis of PCNA-positive cells in
(A).
(C) Disorganized calcein double labeling in the
tibia cortical bone of 3-month-old Ptch1c/;HOC-
Cre mice (n = 3).
(D) Fluorescent TUNEL assay of the trabecular
region of P23 mouse humerus. Apoptotic cells
are stained green.
(E) Statistical analysis of apoptotic cells in (D).
(F) Fluorescent immunohistochemistry of phos-
phohistone-3 (PH3) (arrow) of primary calvarial
osteoblast culture from newborn mice.
(G) Statistical analysis of PH3-positive cells in (F).
(H) Fluorescent TUNEL assay of the same osteo-
blast culture as in (F).
(I) Statistical analysis of apoptotic cells in (H).
All dataaremeans±SDof three individual samples.
Nucleus is stained by DAPI (blue). Autofluorescent
red blood cells are green with no DAPI staining.
teoblast proliferation and differentiation
with osteoclast induction is disrupted
when Hh signaling is upregulated in the
mature osteoblasts. In the Ptch1c/;
HOC-Cre mutant mice, the number of
osteoblasts was increased (Figures 2E
and 2G). However, the increase in the
number of tartrate-resistant acid phos-
phatase (TRAP)-positive multinucleated
osteoclasts was more significant (Figures
2F and 2G). These observations suggest
that enhanced bone resorption is domi-
nant over increased bone formation
when Hh signaling was cell-autonomously upregulated inmature
osteoblasts.
To test whether increased bone formation was caused by
altered osteoblast proliferation and/or survival, we examined
the expression of proliferating cell nuclear antigen (PCNA) (Fig-
ures 3A and 3B) and performed TUNEL assays (Figures 3D
and 3E). In the Ptch1c/;HOC-Cre bone section, there weremore
PCNA-positive osteoblasts. Furthermore, we assessed bone
formation rate by in vivo calcein double labeling (Figure 3C).
Ptch1c/;HOC-Cre mice showed increased calcein incorpora-
tion without consistent double labeling, reflecting the increased
number and disorganization of the osteoblasts during the rapid
osteogenesis that resulted in woven bone (Figures 3C and 2E).
In addition, TUNEL assay showed fewer apoptotic osteo-
blasts in the Ptch1c/;HOC-Cre mice (Figures 3D and 3E).
These results indicate that upregulated Hh signaling in ma-
ture osteoblasts leads to accelerated bone formation by pro-
moting cell proliferation and survival. To further test whether
this function of Hh signaling is cell autonomous, we isolated
primary calvarial osteoblasts and cultured them in vitro. Cell
proliferation was increased in the Ptch1c/;HOC-Cre primaryDevelopmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc. 677
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Hh Controls Bone Homeostasis via PTHrP and RANKLFigure 4. Hh Signaling Promotes Osteoblast Maturation
(A) Gene expression was examined by QRT-PCR. Total RNA was isolated from 2.5-month-old mouse limbs.
(B) Hh signaling was upregulated by Cre-adenovirus infection of Ptch1c/c calvarial osteoblasts. Early osteoblast differentiation was shown by AP staining.
(C) von Kossa and Alizarin Red staining of the similar osteoblast cultures as in (B).
(D–F) QRT-PCR results using the RNA isolated from the calvarial cultures as described in (B) and (C). All data are means ±SD from triplicate samples.cells, indicated by increased phosphohistone-3 (PH3)-positive
cells (Figures 3F and 3G). However, no difference in apopto-
sis was detected in the mutant and wild-type primary osteo-
blasts (Figures 3H and 3I), suggesting that upregulated Hh
signaling in the Ptch1c/;HOC-Cre mice protected osteo-
blasts from apoptosis caused by their interactions with the
in vivo environment.678 Developmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc.To test whether bone overgrowth in the Ptch1c/;HOC-Cre
mice can also be caused by enhanced osteoblast differentiation
due to upregulated Hh signaling, we examined gene expression
associated with osteoblast differentiation in the adult bone by
quantitative RT-PCR (QRT-PCR) (Figure 4A). As expected, there
was no change in the initial osteoblast differentiation indicated
by Runx2 expression. However, further differentiation of
Developmental Cell
Hh Controls Bone Homeostasis via PTHrP and RANKLcommitted osteoblasts was enhanced as expression of Osterix
(Osx), Osteocalcin (Oc), a marker for mature osteoblasts, and
dentin matrix protein 1 (Dmp1), an early osteocyte marker,
were increased. In addition, expression of Tcf1, a transcription
factor that mediates Wnt/b-catenin signaling, was upregulated
(Galceran et al., 1999; Glass et al., 2005), suggesting that Hh sig-
naling in osteoblasts may enhance Wnt/b-catenin signaling.
To investigate the cell-autonomous effect of Hh signaling on
osteoblast differentiation and maturation, osteoblast differentia-
tion and gene expression were examined in cultured primary
calvarial osteoblasts. Hh signaling was upregulated by infecting
the Ptch1c/c calvarial cells with the Cre-adenovirus (Figures 4B
and 4C). Early osteoblast differentiation was monitored by alka-
line phosphotase (AP) activity. At all stages examined, there was
no significant difference in AP staining between Cre-adenovirus-
infected and uninfected Ptch1c/c cells. However, when osteo-
blast maturation was assayed by Von Kossa or Alizarin Red
staining, mineralized bone nodule formation was increased in
the Cre-adenovirus-infected Ptch1c/c cells compared to those
uninfected controls by day 14 of culture (Figure 4C). Cre-adeno-
virus infection did not increase bone nodule formation in the
wild-type primary osteoblast culture (data not shown). Further-
more, enhanced bone nodule formation was associated with
increased expression of Runx2, Osx, and Osteocalcin as early
as day 6 of culture (Figures 4D–4F). Upregulation of Osx and
Oc expression in the Cre-adenovirus-infected Ptch1c/c calvarial
cells was not as significant as that in the Ptch1c/;HOC-Cre
calvarial cells, possibly due to less efficient conversion from
Ptch1c/c cells to Ptch1/ cells by Cre-adenovirus infection
(compare Figures S4A and S4B with Figures S4C and S4D).
Since Cre-recombinase activity was not detected in the
osteoclast lineage (Figure S5), significantly increased TRAP+
multinucleated osteoclasts in the Ptch1c/;HOC-Cre mice was
due to the non-cell-autonomous role of Hh signaling in osteo-
blasts. To confirm this, we performed coculture assays
(Figure 5A). Isolated calvarial cells from either wild-type or
the Ptch1c/;HOC-Cre mice were allowed to differentiate into
osteoblasts in vitro. These osteoblasts were then cocultured
with FACS-sorted hematopoietic mononucleated precursors of
osteoclasts from the bone marrow (BMMC) of either wild-type
or the Ptch1c/;HOC-Cre mice. Only the osteoblasts from the
Ptch1c/;HOC-Cre mice robustly induced osteoclast formation
from the wild-type BMMC. Wild-type osteoblasts exhibited
similar abilities in inducing osteoclast formation from either the
wild-type or the Ptch1c/;HOC-Cre BMMC (Figures 5A and
5B). These results demonstrate that Hh signaling acts within
osteoblasts to induce osteoclast differentiation.
Hh Signaling in Osteoblasts Promotes Osteoclast
Formation by Upregulating PTHrP
and RANKL Expression
The non-cell-autonomous activity of Hh signaling in osteoblasts
to induce osteoclast differentiation prompted us to identify
secreted factors produced in the osteoblasts that are regulated
by Hh signaling. RANKL and OPG stand out as candidates
because they are major regulators of osteoclast differentiation
and expressed in osteoblasts. Indeed, in the long bones of the
adult Ptch1c/;HOC-Cre mouse limbs, RANKL and OPG ex-
pression was increased, but the increase of RANKL expressionDwas more dramatic (Figure 5C). Furthermore, the expression of
PTHrP, a downstream target of Hh signaling during embryonic
cartilage development, was upregulated in the bone of the
Ptch1c/;HOC-Cre mice (Figure 5C). The expression of PTH,
which signals through the same receptor as PTHrP, was not
upregulated.Cre-adenovirus-infectedPtch1c/c calvarial cells also
showed an increase in the expression of RANKL (Figure 5D)
and PTHrP (Figure 5E). Interestingly, such increase happened
earlier than that of the osteoblast markers we examined (Figures
4D–4F), suggesting that regulation ofRANKL and PTHrP expres-
sion by Hh signaling does not depend on the status of osteoblast
differentiation. There was no significant difference in OPG
(Figure 5F) and PTH (Figure 5G) expression between
Cre-adenovirus-infected and uninfected cells. Taken together,
these data indicate that Hh signaling induces bone resorption in
the postnatal bone by increasing the ratio of RANKL to OPG ex-
pression in mature osteoblasts.
PTHrP Mediates the Activity of Hh Signaling
in Regulating RANKL Expression
Since PTHrP and PTH signal to osteoblasts to induce osteoclast
formation through RANKL expression, our data suggest that
PTHrP acts downstream of Hh signaling in promoting RANKL
expression. To test this, calvarial cells from the wild-type and
Ptch1c/;HOC-Cremice were isolated and cultured in vitro under
osteogenic conditions. Consistent with previous findings
(Thomas et al., 1999), PTHrP-treated wild-type cells showed
upregulatedRANKL expression and downregulatedOPG expres-
sion (Figure 5H). Such alteration in gene expression was not in-
hibited by a Hh-signaling inhibitor Cyclopamine (Cooper et al.,
1998; Figure 5H). In contrast, upregulation of PTHrP and RANKL
expression in the Ptch1c/;HOC-Cre cells was inhibited by Cy-
clopamine (Figure 5H). Furthermore, PTHrP restored RANKL ex-
pression inhibited by Cyclopamine in the Ptch1c/;HOC-Cre cells
(Figure 5H). These results indicate that PTHrPmediates the effect
of Hh signaling in promoting RANKL expression. To test whether
Hh signaling requires PTHrP to regulate RANKL expression, wild-
type and PTHrP/ calvarial cells were treatedwith Sonic Hedge-
hog (Shh). Shh increased RANKL and PTHrP expression in the
wild-type, not the PTHrP/ cells (Figure 5K). In addition, in
the coculture assay, while Ptch1c/;HOC-Cre osteoblasts in-
duced more osteoclast formation, such increase was abol-
ished by PTHrP-neutralizing antibodies (Figures 5I and 5J).
These results demonstrate that PTHrP is both necessary and
sufficient to mediate the effect of Hh signaling in promoting
RANKL expression and osteoclast differentiation.
PTHrP Regulates RANKL Expression through
PKA and CREB
To understand the underlying molecular mechanism whereby
PTHrP signaling controls RANKL expression in osteoblasts, we
searched the transcription factors that have been reported to
regulate RANKL expression directly. Among these, CREB and
ATF4 were strong candidates. CREB and ATF4 are members
of the CREB family of basic leucine zipper transcription factors,
which bind the cyclic AMP-responsive element (CRE) as homo-
dimers or heterodimers and activate transcription upon phos-
phorylation by PKA (Shaywitz and Greenberg, 1999). CREB
and ATF4 have been shown to control RANKL expression inevelopmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc. 679
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Hh Controls Bone Homeostasis via PTHrP and RANKLFigure 5. Hh Signaling Acts in Osteoblasts to Promote Osteoclast Formation
(A) TRAP staining of osteoblasts (ob)/bone marrow monocytes (BMMC) cocultures.
(B) Statistical analysis of TRAP-positive cell numbers in the cocultures shown in (A). TRAP-stained cells were counted in triplicates.
(C) Gene expression was examined by QRT-PCR. Total RNA was isolated from 2.5-month-old mouse limbs.680 Developmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc.
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Hh Controls Bone Homeostasis via PTHrP and RANKLosteoblasts by directly binding a CRE site in the RANKL pro-
moter (Elefteriou et al., 2005; Ishida et al., 2002). In addition,
the common receptor of PTH and PTHrP activates adenylyl cy-
clase (AC)/protein kinase A (PKA) (Bringhurst et al., 1993; Fuji-
mori et al., 1992). Since PTH can still activate RANKL expression
in the ATF4/ osteoblasts (Elefteriou et al., 2005), we tested our
hypothesis that PTHrP promotes RANKL expression by activat-
ing PKA and its target transcription factor CREB. Using anti-
bodies that specifically recognize the CREB phosphorylated by
PKA (pCREB), we found that in bone sections, CREB is more ro-
bustly phosphorylated by PKA in Ptch1c/;HOC-Cre osteoblasts
as compared to the wild-type control (Figure 6A). CREB tran-
scription activity was also upregulated in the Ptch1c/;HOC-
Cre osteoblasts (Figure 6B). In addition, treating primary calvarial
osteoblasts with PTHrP leads to fast (within 10 min) and robust
CREB phosphorylation (Figure 6C). The level of phosphorylation
was similar to that caused by Forskolin (a cAMP-elevating agent)
treatment or expression of an activated form of PKA. Further-
more, inhibition of PKA by H89 abolished PTHrP-induced
CREB phosphorylation (Figure 6C). To test whether PKA and
CREBmediate the activity of PTHrP in regulatingRANKL expres-
sion, we treated primary calvarial osteoblasts with PTHrP in the
presence H89 or an adenovirus that carries a dominant-negative
CREB (aCREB-Adenovirus) that can block the transcriptional
activity of all CREB family members (Chen et al., 2005). RANKL
upregulation by PTHrP or Shh or in the Ptch1c/;HOC-Cre oste-
oblasts was inhibited by H89 and aCREB-Adenovirus infection
(Figures 6D and 6E). To further test whether CREB directly regu-
lates RANKL expression in osteoblasts, we examined the regu-
lation of a 1 kb RANKL promoter that contains CREB-binding
sites (Ishida et al., 2002) by the PTHrP-PKA-CREB pathway.
This RANKL promoter activity was activated by PTHrP but
inhibited by H89 or aCREB-Adenovirus infection even in the
presence of PTHrP (Figure 6F). To test whether pCREB binds
to thisRANKL promoter directly, we performed chromatin immu-
noprecitiation (CHIP) assay. Consistent with the previous obser-
vation which showed by the eletrophoretic mobility shift assay
(EMSA) that CREB mainly binds to the 945 CRE site in the
RANKL promoter upon TGFb treatment (Ishida et al., 2002),
more DNA of the945 region of theRANKL promoter was immu-
nopecipitated by antibodies against CREB or pCREB in the
Ptch1c/;HOC-Cre osteoblasts or upon PTHrP treatment (Fig-
ures 6G and 6H). Taken together, PTHrP signaling regulates
RANKL expression through activating PKA and its target tran-
scription factor CREB that directly binds to theRANKL promoter.
Loss of Hh Signaling in Mature Osteoblasts
Results in High Bone Mass
That cell-autonomous upregulation of Hh signaling in mature
osteoblasts promoted bone resorption raised the possibilitythat active Hh signaling in mature osteoblasts contributed to
bone loss in aged mice. To test this, Hh signaling in the bone
of 3-, 6-, and 12-month-old mice was assessed by the expres-
sion of Hh-signaling target genes Ptch1, Gli1, and Hip1 (Bai
et al., 2002; Chuang and McMahon, 1999; Goodrich et al.,
1996). Hh signaling was lower in the bone of 3-month-old mice
(Figure 7A). Consistent with this, PTHrP and RANKL expression
were slightly upregulated in older mice (Figure 7A). As a result,
osteoblasts from older mice induced more osteoclast formation
when cocultured with the same osteoclast precursors (Fig-
ure S6). We then investigated whether Hh signaling is required
in osteoblasts to control osteoclast differentiation and whether
inhibition of Hh signaling in osteoblasts would protect bone
loss observed in agedmice.Smo, which is required for transduc-
ing Hh signaling, was inactivated in mature osteoblasts in the
Smoc/c;HOC-Cremice. These mice were viable and morpholog-
ically normal throughout their lives. At 2 months of age, no signif-
icant difference in bone morphology and mass was observed in
the mutant mice (Figure S7). About 40% of the conditional allele
had been converted to a null allele and Hh signaling was signif-
icantly reduced in the 1-year-old Smoc/c;HOC-Cre mice
(Figure S4E; Figure 7H). In these 1-year-old mutant mice, tra-
becular bone mass was increased compared to the wild-type
control (Figures 7C–7E). Cortical bone mass in the mutant was
also slightly increased (Figure 7E). Importantly, the 1-year-old
wild-type control mice showed significant trabecular bone loss
compared to the 2-month-old ones (compare Figures 7C and
7D, Fa, with Figures S7B and S7C, Ea). Such age-related
bone loss was much reduced in the Smoc/c;HOC-Cre mutant
mice (compare Figures 7C and 7D, Fe, with Figures S7B and
S7C, Ed). In addition, expression of RANKL and PTHrP was
reduced by removing Smo in osteoblasts (Figure 7G), and
osteoclast number was decreased in both 1-year- and 2-
month-old Smoc/c;HOC-Cre mutant mice (Figure 7F;
Figure S7E). Moreover, expression of osteoblast/osteocyte
markers like Runx2, Osx, Osteocalcin, and Dmp1 was
reduced in the Smoc/c;HOC-Cre mutant bone (Figure 7I). These
changes mirror those observed in the Ptch1c/;HOC-
Cre bone. Together, our data demonstrate that Hh signaling in
mature osteoblasts plays a critical role in controlling postnatal
bone turnover and that its signaling strength is key to age-re-
lated bone loss by regulating the balance of bone formation
and resorption.
DISCUSSION
Hh signaling acts at multiple critical steps in controlling chon-
drocyte and osteoblast proliferation and differentiation during
endochondral bone development. Here, we report that Hh sig-
naling in mature osteoblasts in adult mice promotes bone(D–G) Gene expression was examined by QRT-PCR using the RNA isolated from the calvarial osteoblast cultures described in Figure 4.
(H) Wild-type and Ptch1c/;HOC-Cre calvarial osteoblasts were treated with either PTHrP protein, Cyclopamine, or both. Gene expression was examined by
QRT-PCR.
(I) TRAP staining of cocultured obs with wild-type BMMC. PTHrP-neutralizing antibodies (1:1000) significantly reduced the number of TRAP-positive osteoclasts
in the coculture with Ptch1c/;HOC-Cre obs.
(J) Statistical analysis of TRAP-positive cells in (I).
(K) PTHrP/ calvarial osteoblasts were treated with recombinant Shh protein. Gene expression was examined by QRT-PCR. All data are means ±SD from
triplicate samples.Developmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc. 681
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Hh Controls Bone Homeostasis via PTHrP and RANKLFigure 6. PTHrP Signaling in Osteoblasts Regulates RANKL Expression by Activating PKA and CREB
(A) Immunohistochemistry of pCREB (arrow) in the trabecular bone of P23 mouse humerus. Boxed regions are shown in higher magnification in the lower panel.
(B) CREB transcriptional activity was assessed by the CRE-luciferase reporter assay.
(C) Immunoblots of wild-type calvarial osteoblasts treated with PTHrP and Forskolin for 10min. Osteoblasts expressing a constitutively active form of PKA served
as positive controls.682 Developmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc.
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and survival. More importantly, Hh signaling also acts in osteo-
blasts to regulate osteoclast differentiation by controlling the ex-
pression of PTHrP, which in turn regulates RANKL expression
via PKA and its target transcription factor CREB (Figure 7J).
Our results indicate that in mature osteoblasts, Hh signaling reg-
ulates a delicate balance between bone growth and resorption
via cell-autonomous and non-cell-autonomous mechanisms,
respectively.
Stage andCell Context-Dependent Roles ofHhSignaling
in Bone Formation and Homeostasis
The ligand that activates Hh signaling in the skeletal system is
Ihh. Ihh in the newly formed cartilage is required for osteoblast
differentiation by controlling Runx2 expression in the perichon-
drium. Runx2 then controls the expression of Osx, another
transcription factor also required for osteoblast lineage commit-
ment (Nakashima et al., 2002). Hh signaling is not required in
Osx+ osteoblasts for further osteoblast maturation in mouse
embryos (Rodda and McMahon, 2006). It is not clear whether
Hh signaling is required in the Osx+ osteoblasts during post-
natal bone homeostasis. By inactivating Hh signaling in mature
osteoblasts after Osx expression, we found in this study that
Hh signaling is required to control both postnatal bone formation
and resorption.
In the growth plate, Ihh expression is confined to prehypertro-
phic chondrocytes. A major role of Ihh at this stage is to control
the pace of chondrocyte hypertrophy by activating the
expression of PTHrP, which inhibits chondrocyte hypertrophy
(Kronenberg, 2003). Our data show that Hh signaling in mature
osteoblasts in adult mice also acts by regulating PTHrP expres-
sion, likely through Gli2 andGli3 (Figure S8). Consistent with this,
both PTHrP and upregulated Hh signaling in committed osteo-
blast precursors promoted their differentiation and reduced their
apoptosis (Miao et al., 2005; Figure 3). As shown in Ohba et al.
2008 (in this issue of Developmental Cell), Hh signaling may
also regulate osteoblast differentiation directly by inhibiting the
production of Gli3 repressor, which inhibits Runx2 transcription
activity. More importantly, PTHrPmediates the non-cell-autono-
mous role of Hh signaling in inducing osteoclast differentiation
through regulating RANKL expression. This is consistent with
the previous finding that sustained PTHrP expression leads
to increased bone resorption (Ma et al., 2001). Our data
further indicate that PTHrP regulates RANKL expression by
activating PKA and its target transcription factor CREB. We
should point out here that other CREB family members including
ATF4 may also act downstream of PKA to regulate RANKL ex-
pression.
Since PTHrP stimulates both bone formation and resorption in
early differentiated osteoblasts, PTHrP expression must be
tightly regulated both temporally and spatially in order to control
bone formation and avoid increased osteoclast differentiation.
Our studies indicate that Hh signaling represents a critical regu-latory mechanism for the temporal and spatial control of PTHrP
expression (Figure 7J). Ihh expression and activity are de-
tected in the growth plate chondrocytes and early differenti-
ated osteoblasts. Hh signaling decreases progressively as
the osteoblasts mature and are further away from the growth
plates (Figure 1). This distribution of Hh signaling activity corre-
lates very well with the expression pattern of PTHrP in osteo-
blasts and the ability of osteoblasts to induce osteoclast differ-
entiation. Osteogenic progenitors produce PTHrP at early
differentiation stages, and PTHrP levels decrease with further
osteoblast maturation (Miao et al., 2005; Suda et al., 1996).
In addition, Hedgehog ligands promote both PTHrPmRNA ex-
pression and PTHrP secretion in primary osteoblast cultures
(Jemtland et al., 2003). Therefore, our work identifies PTHrP
as one of the critical downstream targets of Hh signaling in
postnatal bone homeostasis. Our data also indicate that Hh
signaling needs to be kept at a low level in mature osteoblasts
to ensure low PTHrP expression and prevent excessive osteo-
clast formation.
The roles of Hh signaling in bone homeostasis obviously de-
pend on the signaling strength and the cell context. As shown in
Ohba et al., 2008, the accompanying manuscript, bone mass is
increased in the Ptch1+/mice where Hh signaling is weakly un-
regulated at all developmental stages in all cells. Increased
RANKL expression and bone resorption are also observed in
these mice, but the effect of increased bone formation is stron-
ger. These observations are consistent with the demonstrated
role of Hh signaling in promoting osteoblast differentiation
from mesenchymal progenitors and its function in supporting
proliferation and maturation of early osteoblasts. However,
when Hh signaling is more robustly upregulated by removing
both copies of Patch1 in the Ptch1c/;HOC-Cre osteoblasts,
stronger RANKL expression leads to more bone resorption.
In addition, as Hh signaling is only upregulated in mature
osteoblasts, early differentiation and proliferation of osteo-
blasts are much less affected in the Ptch1c/;HOC-Cre
mice. Therefore, Hh signaling in mature osteoblasts controls
bone homeostasis predominantly by regulating bone
resorption.
Relationship of Hh, Bmp, and Wnt Signaling
in Osteoblasts
Expression of Bone morphogenetic protein 2 (Bmp 2), Bmp 4,
and Bmp 7 was also upregulated in the bone of the Ptch1c/;
HOC-Cre mice (Figure S9A). Bmp signaling promotes bone
formation and stimulates osteoclast differentiation through
a RANKL-independent mechanism (Okamoto et al., 2006).
Bmps may directly signal to osteoclast precursors to promote
osteoclast differentiation (Figure S9D; Okamoto et al., 2006;
Kaneko et al., 2000). In the primary calvarial osteoblasts, we
found that Bmps and PTHrP did not regulate the expression of
each other (data not shown). In addition, inhibition of osteoclast
differentiation by Noggin, a secreted Bmp antagonist, could be(D and E) RANKL expression was examined by QRT-PCR.
(F) Dual luciferase assay of RANKL promoter in wild-type primary osteoblasts.
(G and H) CHIP assay was performed using PTHrP-treated wild-type or Ptch1c/;HOC-Cre calvarial osteoblasts. Q-PCR was performed using primers flanking
the 945 CREB-binding site of the RANKL promoter. Equal DNA input was shown as PCR results using total input DNA. CHIP assay with IgG was shown as
a negative control. All data are means ±SD from triplicate samples.Developmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc. 683
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Hh Controls Bone Homeostasis via PTHrP and RANKLFigure 7. Hh Signaling in Osteoblasts Is Required for Osteoclast Differentiation in Adult Mice
(A and B) Gene expression in the adult mouse bone of indicated ages was analyzed by QRT-PCR.
(C) mCT analyses of sagittal sections of 1-year-old mouse femur of the indicated genotypes. Three-dimensional images of the bracketed trabecular bone region
are shown in (D).684 Developmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc.
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and Bmp may act in parallel to regulate osteoblast and osteo-
clast differentiation downstream of Hh signaling. It will be inter-
esting to further investigate the molecular mechanism of Bmp
signaling in controlling osteoclast differentiation.
Both Hh andWnt/b-catenin signaling pathways are required in
osteoblasts to regulate osteoclast differentiation. Hh signaling
has been placed upstream of Wnt/b-catenin signaling during
early osteoblast differentiation in skeletal development (Hu
et al., 2005; Mak et al., 2006; Rodda and McMahon, 2006). In
the differentiated osteoblasts, Hh signaling activity appears to
be mediated by at least two downstream signaling pathways:
Wnt/b-catenin and PTHrP. While both signaling pathways act
to promote bone formation, they have opposite roles in osteo-
clast differentiation. PTHrP signaling promotes osteoclast differ-
entiation by upregulating RANKL expression and inhibiting OPG
expression. But Wnt/b-catenin signaling inhibits osteoclast
differentiation primarily by upregulating OPG expression. As
Wnt/b-catenin and PTHrP cancel each other’s effect in regulat-
ing OPG expression, Hh signaling controls osteoclast differenti-
ation mainly through RANKL.
Hh Signaling as a Therapeutic Target for Osteoporosis
Hh signaling promotes osteoblast differentiation from me-
senchymal progenitors and osteoblast maturation. Therefore,
augmenting Hh signaling could be beneficial in treating osteo-
porosis.However, upregulatedHhsignalingwill lead to increased
tumor formation as shown in the Gorlin Syndrome patients. In
addition, one must carefully evaluate the differential impacts of
timing, cell types, and strength of Hh signaling on bone formation
versus resorption. Our results indicate that sustained high levels
of Hh signaling in mature osteoblasts will reduce bone quality by
making the bone more porous due to increased osteoclast for-
mation. Growth plates exist in the adult mouse bone for long
time, whereas in humans, growth plates close at puberty. As
growth plate chondrocytes are themajor source of Ihh, the effect
of Hh signaling in adult human bone homeostasis may not be as
strong as inmice. However, Ihh expression is detected in primary
osteoblasts which also respond to Hh signaling. Thus, genetic
mutations that cause Hh signaling activation preferentially in
mature osteoblasts in humans are likely to result in early onset
of osteoporosis. It may be therefore more efficient to increase
bone mass and reduce the risk of tumor formation by alternating
between enhancing and inhibiting Hh signaling periodically to
generate more osteoblasts and pulses of PTHrP expression
that have been shown to favor bone formation versus bone
resorption (Jilka, 2007).EXPERIMENTAL PROCEDURES
Histological Analysis
Whole-mount X-gal staining was performed as previously described (Topol
et al., 2003). Primary antibodies used in immunohistochemistry include anti-
PCNA mouse monoclonal IgG (Santa Cruz) at 1:50, anti-Phosphohistone-3
rabbit polyclonal IgG (Cell Signaling) at 1:100, and anti-phospho-CREB (Ser
133) rabbit polyclonal IgG (Upstate) at 1:100. The signal was detected using
FITC-conjugated secondary antibodies (Molecular Probes) or ABC kits (Vector
Laboratories). Apoptosis was detected as described (Barrow et al., 2003).
TRAP staining was detected according to manufacturer’s protocol (Sigma).
Calcein double labeling was performed as described (Sontag, 1980) except
that calcein was injected at day 10 and 2 before the mice were sacrificed.
Static and dynamic histomorphometric analyses were performed according
to standard protocols (Parfitt et al., 1987).
Calvarial Cell Culture
Calvariae were dissected from P1 to P3 newborn pups. Soft tissue was
removed and the calvariae were washed in PBS and subjected to five sequen-
tial digestions by 0.5% collagenase (Roche) in a-MEM medium at 37C for 25
min each. The cells from the last four digestions were collected and expanded
for subsequent cultures. 2.53 105 cells were seeded per well in 12-well plates
and switched into osteogenic medium with ascorbic acid and glycerophos-
phate after reaching superconfluence.
Quantitative RT-PCR
Quantitative PCR was performed to measure the relative mRNA levels using
Platinum SYBR Green kit (Invitrogen). Samples were normalized with GAPDH
and actin expression.
Coculture Experiments
Primary osteoblasts from calvariae were seeded at 23 105 per well in 24 wells
and cultured in osteogenic medium as described above. Hematopoietic
mononucleated precursors of osteoclasts were isolated from bone marrow
and FACS sorted for TER119 CD4 CD8 Mac-1+ CD45+ cells. 0.8 3 106
sorted cells were seeded per well on top of the calvarial osteoblasts for 10
days. The medium was supplemented with M-CSF (10 ng/ml) and 1, 25 dihy-
droxyvitamin D3 (108 M). Osteoclasts were identified by TRAP staining and
counted in triplicates.
Microcomputed Tomography Analysis
The femurs and calvariae were scanned and reconstructed with 8 mm isotropic
voxels on a microcomputed tomography analysis (mCT) system (eXplore MS,
GE Medical Systems, London, Ontario, Canada). A bone standard (SB3,
Gammex RMI, Middleton, WI) was scanned with the mCT and used for the cal-
ibration of bone-massmeasurements. The reconstructed 3D imagines of distal
femurs and calvariae were analyzed using Microviewer (GE Medical Systems,
London, Ontario, Canada). A fixed threshold was used to separate the bone
and marrow phase. The trabecular BMD and trabecular bone volume per
tissue volume (BV/TV) in the distal femur were measured in a rectangular
cylinder (1.3 mm 3 0.6 mm 3 1.9 mm) within the metaphysis.(E) Histomorphometric analysis of bone parameters in the femur of 1-year-old mice. Bone mass and bone volume were significantly reduced in the wild-type
mouse. Three individual samples of each genotype were analyzed.
(F) Tibia sections of 1-year-old mice. van Gieson staining is shown in low magnification in (a), (b), (e), and (f). H & E staining of osteoblasts is shown in (c) and (g).
TRAP staining is shown in (d) and (h).
(G) Gene expression was examined by QRT-PCR using RNA isolated from long bones of 1-year-old wild-type or Smoc/c;HOC-Cre mice.
(H and I) Gene expression was examined by QRT-PCR using RNA isolated from long bones of 1-year-old wild-type or Smoc/c;HOC-Cre mice. All data are
means ±SD from triplicate samples.
(J) Proposed model for the action of Hh signaling in regulating osteoclast formation in the adult mouse bone. Part of the adult mouse long bone is schematically
shown. Ihh is strongly expressed in the prehypertrophic chondrocytes in the growth plates. It may also be weakly expressed in the less mature osteoblasts. This
expression pattern of Ihh results in a gradient of Hh signaling activity in the osteoblasts as they mature. This gradient determines that there are cooresponding
gradients of PTHrP and RANKL expression and the ability of osteoblasts in inducing osteoclast formation. See text for details.
PH, prehypertophic chondrocytes; H, hypertrophic chondrocytes; TB, trabecular bone; CB, cortical bone.Developmental Cell 14, 674–688, May 2008 ª2008 Elsevier Inc. 685
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Primary osteoblasts were transfected with Luc reporters by nucleofection
(Amaxa). Procedures were followed as described in the manufacturer’s proto-
col. After nucleofection, cells were recovered for 4–5 hr and then infected by
the aCREB-Adenovirus for 24 hr, serum starved overnight, and treated with
PTHrP (3 mg/ml) and/or H89 (30 mM) for 4 hr. Cells were subjected to luciferase
activity measurement as described in Dual luciferase reporter assay kit
(Promega).
Western Blot Analysis
Primary osteoblasts were transfected with a constitutive active form of PKA.
Transfected and untransfected cells were serum starved overnight. Untrans-
fected cells were treated with PTHrP, H89, and Forskolin (10 mM) for 10 min,
1, 2, and 5 hr. H89 was added to the medium 30 min before adding PTHrP
or Forskolin. Cell lysates were analyzed by western blot as described (Topol
et al., 2003). Primary antibodies used include: rabbit anti-phospho-CREB
(Ser133) and rabbit anti-CREB (Upstate).
Chromatin Immunoprecipitation
Primary osteoblasts (13106 cells) were fixed with 1% formaldehyde directly in
culture medium at 37C for 10 min. Cells were sonicated for four cycles of 10 s
each. Immunoprecipitation was performed using the Chromatin immunopre-
cipitation (CHIP) assay kit (Upstate) with rabbit anti-CREB antibody (Upstate)
and rabbit anti-phospho-CREB antibody (Upstate).
SUPPLEMENTAL DATA
Supplemental Data include nine figures and can be found with this article
online at http://www.developmentalcell.com/cgi/content/full/14/5/674/DC1/.
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